About
Bridging Biopharma Across Borders
SinoBiologics LLC is a specialized business development advisory firm helping mid-size biopharma companies unlock cross-border licensing and partnership opportunities across the US, China, and EU.
Our Mission
Precision BD for a Complex World
The global biopharma landscape has never been more interconnected — or more complex. Licensing deals that once took years now require navigating multiple regulatory environments, cultural expectations, and commercial frameworks simultaneously.
SinoBiologics was founded to bridge that complexity. We combine deep scientific fluency with decades of cross-border deal experience to help our clients identify the right partners, structure the right terms, and close the right deals — faster and with greater confidence.
We work exclusively with mid-size biopharma companies where BD outcomes have an outsized impact on pipeline trajectory and company value. Our clients trust us to act as a true extension of their team — with the networks, expertise, and cultural intelligence to operate effectively across three of the world's most important biopharma markets.
What Sets Us Apart
Built for Cross-Border Complexity
Trilateral Market Expertise
Deep operational experience across US, China, and EU regulatory and commercial environments — not just familiarity, but active deal networks in all three markets.
Scientific Fluency
Our team speaks the language of drug development. We engage credibly with scientific and clinical leadership, enabling more productive partner conversations from day one.
Deal-Focused Approach
We measure success by signed agreements, not activity. Every engagement is structured around a clear path to term sheet and close.
Confidential & Conflict-Free
We represent one side of every deal. Our clients receive undivided attention and advice that is always aligned with their interests.
Therapeutic Focus
Where We Work
We have deep experience across a range of therapeutic areas, with particular strength in complex biologics and precision medicine.
Oncology
Solid tumors, hematologic malignancies, immuno-oncology
Immunology
Autoimmune, inflammatory, and rare immune disorders
Rare Disease
Orphan indications with high unmet need
CNS
Neurodegenerative and neuropsychiatric conditions
Metabolic
Cardiometabolic and endocrine disorders
Infectious Disease
Antiviral and antibacterial biologics
Ready to Explore a Partnership?
Schedule a confidential conversation to discuss your pipeline and BD objectives.